Background And Objective: Multi-atlas based segmentation techniques, which rely on an atlas library comprised of training images labeled by an expert, have proven their effectiveness in multiple automatic segmentation applications. However, the usage of exhaustive patch libraries combined with the voxel-wise labeling incur a large computational cost in terms of memory requirements and execution times.
Methods: To confront this shortcoming, we propose a novel two-stage multi-atlas approach designed under the Semi-Supervised Learning (SSL) framework. The main properties of our method are as follows: First, instead of the voxel-wise labeling approach, the labeling of target voxels is accomplished here by exploiting the spectral content of globally sampled datasets from the target image, along with their spatially correspondent data collected from the atlases. Following SSL, voxels classification is boosted by incorporating unlabeled data from the target image, in addition to the labeled ones from atlas library. Our scheme integrates constructively fruitful concepts, including sparse reconstructions of voxels from linear neighborhoods, HOG feature descriptors of patches/regions, and label propagation via sparse graph constructions. Segmentation of the target image is carried out in two stages: stage-1 focuses on the sampling and labeling of global data, while stage-2 undertakes the above tasks for the out-of-sample data. Finally, we propose different graph-based methods for the labeling of global data, while these methods are extended to deal with the out-of-sample voxels.
Results: A thorough experimental investigation is conducted on 76 subjects provided by the publicly accessible Osteoarthritis Initiative (OAI) repository. Comparative results and statistical analysis demonstrate that the suggested methodology exhibits superior segmentation performance compared to the existing patch-based methods, across all evaluation metrics (DSC:88.89%, Precision: 89.86%, Recall: 88.12%), while at the same time it requires a considerably reduced computational load (>70% reduction on average execution time with respect to other patch-based). In addition, our approach is favorably compared against other non patch-based and deep learning methods in terms of performance accuracy (on the 3-class problem). A final experimentation on a 5-class setting of the problems demonstrates that our approach is capable of achieving performance comparable to existing state-of-the-art knee cartilage segmentation methods (DSC:88.22% and DSC:85.84% for femoral and tibial cartilage respectively).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2022.107208 | DOI Listing |
Neurol Neuroimmunol Neuroinflamm
March 2025
Department of Neurology with Institute of Translational Neurology, University Hospital 4 Münster, Germany.
Background And Objectives: Levels of activated complement proteins in the CSF are increased in people with multiple sclerosis (MS) and are associated with clinical disease severity. In this study, we determined whether complement activation profiles track with quantitative MRI metrics and liquid biomarkers indicative of disease activity and progression.
Methods: Complement components and activation products (Factor H and I, C1q, C3, C4, C5, Ba, Bb, C3a, C4a, C5a, and sC5b-9) and liquid biomarkers (neurofilament light chain, glial fibrillary acidic protein [GFAP], CXCL-13, CXCL-9, and IL-12b) were quantified in the CSF of 112 patients with clinically isolated syndromes and 127 patients with MS; longitudinal MRIs according to a standardized protocol of the Swiss MS cohort were assessed.
ACS Appl Mater Interfaces
January 2025
Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou 510630, China.
Epstein-Barr nuclear antigen 1 (EBNA1), a sequence-specific DNA binding protein of Epstein-Barr virus (EBV), is essential for viral genome replication and maintenance and is therefore an attractive target for the therapeutic intervention of EBV-associated cancers. Several EBNA1-specific inhibitors have demonstrated the ability to block EBNA1 function in vitro, but practical delivery strategies for these inhibitors in vivo are still lacking. Here, we report an intelligent hierarchical targeting theranostic nanosystem (denoted as mZGOCS@MnO-P5) that integrates an azide (N3) terminal dual-targeting peptide (N3-P5), a tumor microenvironment-responsive degradable MnO nanosheet, and a mesoporous ZnGaO:Cr, Sn near-infrared persistent luminescence (NIR-PL) nanosphere (mZGOCS).
View Article and Find Full Text PDFAnal Chem
January 2025
Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Applications of Ministry of Education, Hunan Provincial University Key Laboratory for Environmental and Ecological Health, College of Chemistry, Xiangtan University, Xiangtan 411105, P.R. China.
The challenge of "false positive" signals significantly complicates tumor localization and surgical resection, which are pivotal for successful tumor surgeries. Therefore, the development of a method for preoperative tumor localization and intraoperative margin determination holds considerable promise for improving surgical outcomes. In this study, a zero-crosstalk ratiometric tumor-targeting near-infrared (NIR) fluorescent probe was developed for precise cancer diagnosis and intraoperative navigation via NIR fluorescence imaging.
View Article and Find Full Text PDFSci Adv
January 2025
Department of Biochemistry Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Lysosomal pH dysregulation is a critical element of the pathophysiology of neurodegenerative diseases, cancers, and lysosomal storage disorders (LSDs). To study the role of lysosomes in pathophysiology, probes to analyze lysosomal size, positioning, and pH are indispensable tools. Here, we developed and characterized a ratiometric genetically encoded lysosomal pH probe, RpH-ILV, targeted to a subpopulation of lysosomal intraluminal vesicles.
View Article and Find Full Text PDFSci Adv
January 2025
Department of Cardiac Surgery, Peking University Third Hospital, Beijing 100191, China.
Following myocardial infarction (MI), the accumulation of CD86-positive macrophages in the ischemic injury zone leads to secondary myocardial damage. Precise pharmacological intervention targeting this process remains challenging. This study engineered a nanotherapeutic delivery system with CD86-positive macrophage-specific targeting and ultrasound-responsive release capabilities.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!